MPL
Company Details
Linkedin ID:
macleods-pharmaceuticals-ltd.
Website:
Employees number:
11,522
Number of followers:
126,567
NAICS:
3254
Industry Type:
Homepage:
macleodspharma.com
IP Addresses:
0
Company ID:
MAC_2163538
Scan Status:
In-progress
MACLEODS PHARMACEUTICALS LTD. Company CyberSecurity Posture
macleodspharma.com
A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.
MACLEODS PHARMACEUTICALS LTD. A.I CyberSecurity Scoring
MPL Risk Score (AI oriented)Between 750 and 799
MPL
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
MPL Global Score (TPRM)XXXX
MPL
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
MPL Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
MPL Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for MPL
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2025.
Incident Types MPL vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2025.
Incident History — MPL (X = Date, Y = Severity)
MPL cyber incidents detection timeline including parent company and subsidiaries
MPL Company Subsidiaries
A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.
Loading...
MPL Similar Companies
Takeda
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by list
Ipca Laboratories Limited
A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need
Sandoz
Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health c
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and
AUROBINDO PHARMA LTD
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active
Cipla
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purp
EMS is the leading pharmaceutical company in Brazil. Established since 45 years and with 100% national capital, the company has two industrial plants strategically placed in São Bernardo do Campo and Hortolândia, in the state of São Paulo. With a work based on daring, simplicity, excellence and res
Johnson & Johnson Innovative Medicine
At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently addre
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working t
.png)
MPL CyberSecurity News
October 04, 2025 05:30 AM
Girdhari Lal Bawri, Banwari Lal Bawri and Rajendra Agarwal
Three brothers, whose family owned a pharmacy in Jaipur, set up Macleods Pharmaceuticals in 1986 to make anti-TB medicines.
September 04, 2024 07:00 AM
Celebrating Pharma Excellence & Innovation: The 6th Elets Pharma Leadership Summit & Awards 2024
The event garnered deep insights into current trends, challenges, and opportunities, engaging over 175 senior delegates, industry leaders, and innovators.
July 31, 2021 04:51 PM
Girdhari Lal Bawri
Girdharilal Bawri is the chairman of Macleods Pharmaceuticals, which is among India's top 10 pharma firms. Bawri, whose family owned a pharmacy in Jaipur,...
May 09, 2021 11:58 AM
Banwari Lal Bawri
Banwari Lal Bawri is the joint managing director of privately held Macleods Pharmaceuticals, which is among India's top 10 pharma firms.
August 01, 2016 07:04 AM
Rajendra Agarwal
Medical doctor, whose family owned a pharmacy in Jaipur, set up Macleods Pharmaceuticals with his two brothers in 1986 to make anti-TB medicines.
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
MPL CyberSecurity History Information
Official Website of MACLEODS PHARMACEUTICALS LTD.
The official website of MACLEODS PHARMACEUTICALS LTD. is https://www.macleodspharma.com.
MACLEODS PHARMACEUTICALS LTD.’s AI-Generated Cybersecurity Score
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD.’s AI-generated cybersecurity score is 774, reflecting their Fair security posture.
How many security badges does MACLEODS PHARMACEUTICALS LTD.’ have ?
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does MACLEODS PHARMACEUTICALS LTD. have SOC 2 Type 1 certification ?
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. is not certified under SOC 2 Type 1.
Does MACLEODS PHARMACEUTICALS LTD. have SOC 2 Type 2 certification ?
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. does not hold a SOC 2 Type 2 certification.
Does MACLEODS PHARMACEUTICALS LTD. comply with GDPR ?
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. is not listed as GDPR compliant.
Does MACLEODS PHARMACEUTICALS LTD. have PCI DSS certification ?
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. does not currently maintain PCI DSS compliance.
Does MACLEODS PHARMACEUTICALS LTD. comply with HIPAA ?
According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. is not compliant with HIPAA regulations.
Does MACLEODS PHARMACEUTICALS LTD. have ISO 27001 certification ?
According to Rankiteo,MACLEODS PHARMACEUTICALS LTD. is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of MACLEODS PHARMACEUTICALS LTD.
MACLEODS PHARMACEUTICALS LTD. operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at MACLEODS PHARMACEUTICALS LTD.
MACLEODS PHARMACEUTICALS LTD. employs approximately 11,522 people worldwide.
Subsidiaries Owned by MACLEODS PHARMACEUTICALS LTD.
MACLEODS PHARMACEUTICALS LTD. presently has no subsidiaries across any sectors.
MACLEODS PHARMACEUTICALS LTD.’s LinkedIn Followers
MACLEODS PHARMACEUTICALS LTD.’s official LinkedIn profile has approximately 126,567 followers.
NAICS Classification of MACLEODS PHARMACEUTICALS LTD.
MACLEODS PHARMACEUTICALS LTD. is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
MACLEODS PHARMACEUTICALS LTD.’s Presence on Crunchbase
No, MACLEODS PHARMACEUTICALS LTD. does not have a profile on Crunchbase.
MACLEODS PHARMACEUTICALS LTD.’s Presence on LinkedIn
Yes, MACLEODS PHARMACEUTICALS LTD. maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/macleods-pharmaceuticals-ltd..
Cybersecurity Incidents Involving MACLEODS PHARMACEUTICALS LTD.
As of December 11, 2025, Rankiteo reports that MACLEODS PHARMACEUTICALS LTD. has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
MACLEODS PHARMACEUTICALS LTD. has an estimated 5,413 peer or competitor companies worldwide.
MACLEODS PHARMACEUTICALS LTD. CyberSecurity History Information
How many cyber incidents has MACLEODS PHARMACEUTICALS LTD. faced ?
Total Incidents: According to Rankiteo, MACLEODS PHARMACEUTICALS LTD. has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at MACLEODS PHARMACEUTICALS LTD. ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.
Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=macleods-pharmaceuticals-ltd.' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
